-
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
-
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
-
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
-
Bioventus Reports First Quarter Financial Results
-
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
-
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
-
Bioventus (BVS) Reports Prelim Q1 Sales of $116.5M-$118.5M, Adjusted EBITDA of ($19.4M)-($19M)
-
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
-
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
-
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

